OTC Celebrates World Intellectual Property Day

The Office of Technology Commercialization (OTC) is hosting an Open House on World Intellectual Property Day, April 26 from 8:00 a.m. - 5:00 p.m. Stop by A141 in the ASTeCC Building and learn more about OTC and UK Women Innovators. 


Learn More
World IP Day

By The Numbers

40 new patents

issued to UK in FY2017

$2.39 million

in gross royalty income in FY 2017

600+ worldwide patents

available for licensing with corporate & industry partners

117 licenses & options

active as of June 30, 2017

$3.75 million

in income distributed to inventors since 2010

$13.37 million

income distributed to colleges & departments since 2010

Featured Innovator Dr. Linda P. Dwoskin

Dr. Linda P. Dwoskin

Dr. Linda P. Dwoskin holds an endowed University Professorship in graduate medical education at the University of Kentucky College of Pharmacy. Dr. Dwoskin has been a trailblazer for women in technology transfer at UK. Her entrepreneurial journey began when a company licensed a UK patent on which she and her colleague Peter A. Crooks were inventors. The patent was on several of their smoking cessation products. Drs. Dwoskin and Crooks decided to start up a company called Yaupon Therapeutics. Their business model was patterned after the National Institute of Health's (NIH) business model for grant applications using the "just-in-time" approach. Dr. Dwoskin noted the importance of having a business person involved from the beginning since as an academic researcher she wasn't trained in business. According to Dr. Dwoskin, she was able to learn a lot about business that she didn't know through the partnership and collaboration with the business person who was the CEO of their company. In their third year, Yaupon Therapeutics won the prestigious Best LifeSciences Start-up Company of the Year at the Eastern Technology Council's 13th Annual Enterprise Award, which created interest from venture capitalists. Eventually, Yaupon Therapeutics was sold to another pharmaceutical company, Actelion.

Dr. Dwoskin believes that to date her most significant accomplishment has been the U19 award from the NIH on the discovery of selective nicotinic receptor antagonists. Dwoskin’s team of investigators were successful in obtaining cooperative program project funding aimed at discovering a new class of smoking cessation agents. At the time, this grant was the biggest grant the UK College of Pharmacy had ever received. Several compounds discovered as part of this project are now being used as pharmacological tools and are sold by Sigma.

During her time at UK, Dr. Dwoskin became the first woman appointed as associate dean of research at the UK College of Pharmacy, and she has paved the way for more women to achieve success. Although she spends much of her time and effort in her field of research, she also has become a leader and mentor to many young women. She takes the time to encourage them to go after the careers they want to pursue, and not to let apparent obstacles get in their way. Dr. Dwoskin also provides professional advice and assistance to women in science at other universities that she meets in her professional travels. Dr. Dwoskin was recognized at the Office of Technology Commercialization's (OTC) event, Patent Palooza! Tuesday, for reaching twenty patents issued through the University of Kentucky.